Prokidney (PROK) Receivables - Accured (2023 - 2026)

Prokidney (PROK) has reported Receivables - Accured for 4 consecutive years, with $956000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables - Accured fell 46.14% year-over-year to $956000.0 in Q2 2026; TTM through Jun 2026 was $956000.0, a 46.14% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, down 53.94% from the prior year.
• Receivables - Accured was $956000.0 for Q2 2026 at Prokidney, down from $1.0 million in the prior quarter.
• Over five years, Receivables - Accured peaked at $8.1 million in Q2 2023 and troughed at $714000.0 in Q3 2023.
• A 4-year average of $2.6 million and a median of $1.8 million in 2025 frame the typical range for Receivables - Accured.
• Across the five-year window, Receivables - Accured soared 614.57% in 2024 and slumped 75.75% in 2025, its largest moves.
• Over 4 years, Receivables - Accured stood at $1.4 million in 2023, then surged by 77.96% to $2.4 million in 2024, then tumbled by 53.94% to $1.1 million in 2025, then slipped by 15.17% to $956000.0 in 2026.
• The last three Receivables - Accured figures came in at $956000.0 (Q2 2026), $1.0 million (Q1 2026), and $1.1 million (Q4 2025), per Business Quant data.